Tissue Regenix Group plc (TRX.L)
GBp 59.5
(0.0%)
GBp 59.5
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 23.72 Million | 19.87 Million | 14.35 Million | 12.82 Million | 13.03 Million | 11.61 Million |
| Cost of Revenue | 12.43 Million | 10.73 Million | 8.72 Million | 7.69 Million | 8.06 Million | 6.87 Million |
| Gross Profit | 11.29 Million | 9.13 Million | 5.63 Million | 5.13 Million | 4.97 Million | 4.74 Million |
| Operating Expenses | 11.61 Million | 10.75 Million | 8.61 Million | 9.25 Million | 12.15 Million | 12.95 Million |
| Selling, General and Administrative Expenses | 11.61 Million | 10.75 Million | 8.61 Million | 8.7 Million | 10.78 Million | 11.32 Million |
| Research and Development Expenses | - | - | - | 546 Thousand | 1.36 Million | 1.63 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 24.04 Million | 21.48 Million | 17.34 Million | 16.94 Million | 20.21 Million | 19.83 Million |
| Operating Income | -394 Thousand | -1.61 Million | -2.98 Million | -4.11 Million | -7.18 Million | -8.21 Million |
| Interest Expense | 1.13 Million | 670.57 Thousand | 503.16 Thousand | 445 Thousand | 477 Thousand | 332.45 Thousand |
| Income Tax Expense | -12 Thousand | -188.34 Thousand | -114.15 Thousand | -533 Thousand | -554 Thousand | -620 Thousand |
| Earnings before Tax | -1.34 Million | -2.29 Million | -3.73 Million | -10.24 Million | -7.66 Million | -8.87 Million |
| Net Income | -1.71 Million | -2.18 Million | -3.48 Million | -9.7 Million | -6.97 Million | -8.18 Million |
| Earnings Per Share Basic | -0.02 | -0.03 | -0.05 | -0.22 | -0.60 | -0.70 |
| Earnings Per Share Diluted | -0.02 | -0.03 | -0.05 | -0.22 | -0.60 | -0.70 |
| Weighted Average Shares Outstanding | 70.42 Million | 70.34 Million | 70.33 Million | 44.47 Million | 11.71 Million | 11.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.42 Million | 70.34 Million | 70.33 Million | 44.47 Million | 11.71 Million | 11.71 Million |
| Gross Margin | 0.48 | 0.46 | 0.39 | 0.40 | 0.38 | 0.41 |
| EBIT Margin | 0.02 | -0.03 | -0.15 | -0.26 | -0.47 | -0.61 |
| Profit Margin | -0.07 | -0.11 | -0.24 | -0.76 | -0.54 | -0.70 |
| EBITDA | 446 Thousand | -690.87 Thousand | -2.18 Million | -9.03 Million | -6.13 Million | -7.03 Million |
| Earnings Before Tax Margin | -0.02 | -0.08 | -0.21 | -0.32 | -0.55 | -0.71 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 12.96 Million | 12.07 Million | 23.72 Million | 11.43 Million | 10.76 Million | 19.87 Million |
| Cost of Revenue | 6.15 Million | 6.49 Million | 12.43 Million | 5.81 Million | 5.79 Million | 10.73 Million |
| Gross Profit | 6.81 Million | 5.58 Million | 11.29 Million | 5.61 Million | 4.97 Million | 9.13 Million |
| Operating Expenses | 6.4 Million | 5.9 Million | 11.61 Million | 5.8 Million | 5.58 Million | 10.75 Million |
| Selling, General and Administrative Expenses | 6.4 Million | 5.7 Million | - | 5.8 Million | 5.58 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 12.55 Million | 12.39 Million | 24.04 Million | 11.62 Million | 11.38 Million | 21.48 Million |
| Operating Income | 413.5 Thousand | -125.5 Thousand | -316.96 Thousand | -189.75 Thousand | -617.39 Thousand | -1.61 Million |
| Interest Expense | 312.3 Thousand | 476.45 Thousand | 1.04 Million | 570.88 Thousand | 393.42 Thousand | 670.57 Thousand |
| Income Tax Expense | 249.84 Thousand | 38.43 Thousand | -9653.66 | -49.46 Thousand | -146.47 Thousand | -188.34 Thousand |
| Earnings before Tax | 105.15 Thousand | -585.96 Thousand | -1.34 Million | -747.66 Thousand | -1 Million | -2.29 Million |
| Net Income | -222.17 Thousand | -643.23 Thousand | -1.37 Million | -724.14 Thousand | -929.07 Thousand | -2.18 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | - | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | -0.00 | -0.01 | - | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 70.59 Million | 70.5 Million | 70.42 Million | 70.19 Million | 70.19 Million | 70.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 70.59 Million | 70.49 Million | 70.42 Million | 70.19 Million | 70.19 Million | 70.34 Million |
| Gross Margin | 0.53 | 0.46 | 0.48 | 0.49 | 0.46 | 0.46 |
| EBIT Margin | 0.06 | 0.02 | - | 0.02 | -0.02 | - |
| Profit Margin | -0.02 | -0.05 | -0.06 | -0.06 | -0.09 | -0.11 |
| EBITDA | 828.6 Thousand | 211.01 Thousand | - | 199.49 Thousand | -189.05 Thousand | - |
| Earnings Before Tax Margin | 0.03 | -0.01 | -0.01 | -0.02 | -0.06 | -0.08 |
MAAL
037460
025750
RTSO
8079
001755